Will Rezafungin Data for Serious Candida Infections Sway FDA Panel?

(MedPage Today) -- Ahead of an advisory committee meeting on Tuesday, FDA staff raised concerns over whether the potential benefits of weekly rezafungin injections for adults with candidemia and invasive candidiasis (IC) outweigh any potential...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news